Abstract
Microbes within the gastrointestinal tract communicate with each other and with the host, which has profound effects on health and disease development. Only now, it is becoming apparent that how and when we acquire our own unique collection of “gut microbes” and also how we choose to maintain them is fundamental to our health. Helicobacter pylori is the most common bacterial infection worldwide, colonizing around half of the world’s population, and is the major risk factor for gastric adenocarcinoma. More recently, it has also been shown to have some beneficial effects in terms of protecting against the development of other diseases. Here, we review the current knowledge on how H. pylori has shaped gastrointestinal microbiota colonization and the host immune system with specific focus on the impact of H. pylori on the various microbiome niches of the gastrointestinal tract. We discuss how the presence of H. pylori influences the physiology of three major regions within the gastrointestinal tract—specifically the oesophagus, stomach and colon. We pay particular attention to the role of H. pylori under chronic inflammatory conditions including the development of cancer. With increased incidence of diseases such as eosinophilic oesophagitis, oesophageal adenocarcinoma and squamous cell carcinoma being attributed to the decline in H. pylori, their disease pathogenesis in light of changing H. pylori colonization is also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L (2008) Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE 3:e2836
Arnold IC et al (2011) Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory t cells. J Clin Invest 121:3088–3093
Arrieta MC et al (2015) Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7:307ra152
Atherton JC, Blaser MJ (2009) Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 119:2475–2487
Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J (2014) Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 4:4202
Backhed F et al (2015) Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:690–703
Benitez AJ et al (2015) Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome 3:23
Bhat S et al (2011) Risk of malignant progression in barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049–1057
Bik EM et al (2006) Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 103:732–737
Blackett KL et al (2013) Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, barrett’s and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther 37:1084–1092
Brawner KM et al (2017) Helicobacter pylori infection is associated with an altered gastric microbiota in children. Mucosal Immunol 10:1169–1177
Castaño-Rodríguez N, Goh KL, Fock KM, Mitchell HM, Kaakoush NO (2017a) Dysbiosis of the microbiome in gastric carcinogenesis. Sci Rep 7:15957
Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM (2017b) Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut 66:235–249
Chen Y, Blaser MJ (2008) Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 198:553–560
Chernikova DA et al (2018) The premature infant gut microbiome during the first 6 weeks of life differs based on gestational maturity at birth. Pediatr Res. https://doi.org/10.1038/s41390-018-0022-z
Coker OO et al (2018) Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 67:1024–1032
Cook MB, Chow WH, Devesa SS (2009) Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. Br J Cancer 101:855–859
Corley DA et al (2008) Helicobacter pylori infection and the risk of barrett’s oesophagus: a community-based study. Gut 57:727–733
De Filippo C et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691–14696
Dellon ES, Hirano (2018) Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology 154:319–332
Den Hollander WJ et al (2015) Intergenerational reduction in Helicobacter pylori prevalence is similar between different ethnic groups living in a western city. Gut 64:1200–1208
Dicksved J, LindberG M, Rosenquist M, Enroth H, Jansson JK, Engstrand L (2009) Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 58:509–516
Dominguez-Bello MG et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107:11971–11975
Eckburg PB et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638
Elliott DE, Urban JJ, Argo CK, Weinstock JV (2000) Does the failure to acquire helminthic parasites predispose to Crohn’s disease? Faseb J 14:1848–1855
Elliott DRF, Walker AW, O’Donovan M, Parkhill J, Fitzgerald RC (2017) A non-endoscopic device to sample the oesophageal microbiota: a case-control study. Lancet Gastroenterol Hepatol 2:32–42
El-omar E et al (1994) Low prevalence of helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 35:1385–1388
Ferreira RM et al (2018) Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 67:226–236
Gao JJ et al (2018) Association between gut microbiota and Helicobacter pylori-related gastric lesions in a high-risk population of gastric cancer. Front Cell Infect Microbiol 8:202
Ge Z et al (2018) Helicobacter pylori-infected C57BL/6 mice with different gastrointestinal microbiota have contrasting gastric pathology, microbial and host immune responses. Sci Rep. 8(1):8014
Graham DY (1997) The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet 350:70–71
Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol 61:1–14
Hansen R et al (2015) First-pass meconium samples from healthy term vaginally-delivered neonates: an analysis of the microbiota. PLoS ONE 10:e0133320
Harris JK et al (2015) Esophageal microbiome in eosinophilic esophagitis. PLoS ONE 10:e0128346
Higgins PD et al (2011) Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis 17:1398–1408
HomaN M, Orel R (2015) Are probiotics useful in Helicobacter pylori eradication? World J Gastroenterol 21:10644–10653
Hsieh YY et al (2018) Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci Rep 8:158
Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P (2011) Incidence of adenocarcinoma among patients with barrett’s esophagus. N Engl J Med 365:1375–1383
Islami F, Kamangar F (2008) Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res 1:329–338
Jakobsson HE, Jernberg C, Andersson AF, Sjolund-Karlsson M, Jansson JK, Engstrand L (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5:e9836
Kienesberger S et al (2018) Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep 14(6):1395–1407
Koenig JE et al (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108(suppl 1):4578–4585
Lee JY et al (2016) Helicobacter pylori infection with atrophic gastritis is an independent risk factor for advanced colonic neoplasm. Gut Liver 10:902–909
Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661–672
Luther J, Dave M, Higgins PD, Kao JY (2010) Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 16:1077–1084
Madan JC et al (2016) Association of cesarean delivery and formula supplementation with the intestinal microbiome of 6-week-old infants. Jama Pediatr 170:212–219
Malaty HM et al (2002) Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 359:931–935
Maldonado-contreras A et al (2011) Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 5:574–579
Marchesi JR et al (2016) The gut microbiota and host health: a new clinical frontier. Gut 65:330–339
May M, Abrams JA (2018) Emerging insights into the esophageal microbiome. Curr Treat Options Gastroenterol 16:72–85
Mcilroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold GL (2018) Review article: the gut microbiome in inflammatory bowel disease—avenues for microbial management. Aliment Pharmacol Ther 47:26–42
Mendall MA et al (1992) Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 339:896–897
Moles L et al (2017) Bacterial diversity of the gastric content of preterm infants during their first month of life at the hospital. Frontiers in Nutrition 4:12
Nam JH et al (2017) Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms. Cancer Causes Control 28:107–115
Noto JM, Peek RM (2017) The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer. PLoS Pathog 13:e1006573
Nowroozilarki N, Jamshidi S, Zahraei Salehi T, Kolahian S (2017) Identification of Helicobacter and Wolinella spp. In oral cavity of toy breed dogs with periodontal disease. Topics in Companion Animal Medicine 32:96–99
Oh B et al (2016) The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial. Helicobacter 21:165–174
O’Keeffe J, Moran AP (2008) Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori. Helicobacter 13:1–19
Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5:e177
Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ (2004) Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A 101:4250–4255
Pei Z, Yang L, Peek RM, Levine SM, Pride DT, Blaser MJ (2005) Bacterial biota in reflux esophagitis and barrett’s esophagus. World J Gastroenterol 11:7277–7283
Posselt G, Backert S, Wessler S (2013) The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal 11:77. https://doi.org/10.1186/1478-811X-11-77
Rad R et al (2006) CD25 +/FoxP3 + T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131:525–537
Rautava S, Luoto R, Salminen S, Isolauri E (2012) Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol 9:565–576
Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW (2001) Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 15:379–388
Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12:2979–2990
Smolka AJ, Backert S (2012) How Helicobacter pylori infection controls gastric acid secretion. J Gastroenterol 47(6):609–618
Smolka AJ, Schubert ML (2017) Helicobacter pylori-induced changes in gastric acid secretion and upper gastrointestinal disease. Curr Top Microbiol Immunol 400:227–252
Snider EJ, Freedberg DE, Abrams JA (2016) Potential role of the microbiome in barrett’s esophagus and esophageal adenocarcinoma. Dig Dis Sci 61:2217–2225
Sohn SH et al (2017) Analysis of gastric body microbiota by pyrosequencing: possible role of bacteria other than Helicobacter pylori in the gastric carcinogenesis. J Cancer Prev 22:115–125
Sonnenberg A, Lash RH, Genta RM (2010) A national study of Helicobacter pylori infection in gastric biopsy specimens. Gastroenterology 139:1894–1901
Sonnenberg A, Turner KO, Spechler SJ, Genta RM (2017) The influence of Helicobacter pylori on the ethnic distribution of barrett’s metaplasia. Aliment Pharmacol Ther 45:283–290
Thorell K et al (2017) In vivo analysis of the viable microbiota and Helicobacter pylori transcriptome in gastric infection and early stages of carcinogenesis. Infect Immun 85:e00031–17
Yamamura K et al (2016) Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res 22:5574–5581
Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z (2009) Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137:588–597
Yassour M et al (2016) Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med 8:343ra81
Yatsunenko T et al (2012) Human gut microbiome viewed across age and geography. Nature 486:222–227
Yu G et al (2017a) Gastric microbiota features associated with cancer risk factors and clinical outcomes: a pilot study in gastric cardia cancer patients from Shanxi, China. Int J Cancer 141:45–51
Yu G et al (2017b) Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol 7:302
Zhang H et al (2018) Helicobacter pylori colonization protects against chronic experimental colitis by regulating Th17/Treg balance. Inflamm Bowel Dis 24:1481–1492
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hold, G.L., Hansen, R. (2019). Impact of the Gastrointestinal Microbiome in Health and Disease: Co-evolution with the Host Immune System. In: Backert, S. (eds) Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori. Current Topics in Microbiology and Immunology, vol 421. Springer, Cham. https://doi.org/10.1007/978-3-030-15138-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-15138-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15137-9
Online ISBN: 978-3-030-15138-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)